Vivo Opportunity Fund, L.P.'s Net Worth
-$18.7 Million
Who is Vivo Opportunity Fund, L.P.?
Vivo Opportunity Fund, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., Crinetics Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, Kadmon Holdings, Inc., Bolt Biotherapeutics, Inc., and Terns Pharmaceuticals, Inc..
SEC CIK
Vivo Opportunity Fund, L.P.'s CIK is 0001726403
Past Insider Trading and Trends
2021 was Vivo Opportunity Fund, L.P.'s most active year for acquiring shares with 19 total transactions. Vivo Opportunity Fund, L.P.'s most active month to acquire stocks was the month of January. 2020 was Vivo Opportunity Fund, L.P.'s most active year for disposing of shares, totalling 25 transactions. Vivo Opportunity Fund, L.P.'s most active month to dispose stocks was the month of January. 2022 saw Vivo Opportunity Fund, L.P. paying a total of $29,684,168.40 for 1,412,437 shares, this is the most they've acquired in one year. In 2022 Vivo Opportunity Fund, L.P. cashed out on 1,855,873 shares for a total of $24,497,523.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +31.95% | 612.44K |
$13.20 | $8,084,168.40 | 2.53M |
Jan 26
| |||
Form 4
| +3,045.01% | 1.86M |
—
|
—
| 1.92M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.02% | -528.00 |
$19.50 | -$10,296.00 | 3.27M |
Mar 9
| |||
Form 4
| -0.21% | -13.46K |
$21.70 | -$291,587.00 | 6.54M |
Feb 7 - Feb 10
| |||
Form 4
| -0.41% | -13.46K |
$22.80 | -$306,888.00 | 3.28M |
Feb 4
| |||
Form 4
| -0.27% | -26.92K |
$22.00 | -$594,164.00 | 9.9M |
Jan 29 - Jan 31
| |||
Form 4
| -11.16% | -417.00K |
$22.25 | -$9,278,250.00 | 3.32M |
Mar 20
| |||
Form 4
| +59.34% | 3.74M |
$17.65 | $6,575,421.40 | 10.04M |
Jul 20
| |||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.22M |
$19.00 | $3,524,994.00 | 4.22M |
Jul 21
| |||
| No matching records found | |||||||||
Kadmon Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8,933.46% | 3.83M |
$16.57 | $2,995,480.00 | 3.87M |
Feb 9
| |||
| No matching records found | |||||||||